KRISTINA DAHLSTROM to Human papillomavirus 16
This is a "connection" page, showing publications KRISTINA DAHLSTROM has written about Human papillomavirus 16.
Connection Strength
3.269
-
Circulating tumor HPV DNA, antibodies to HPV16 early proteins, and oral HPV16 DNA as biomarkers for HPV-related oropharyngeal cancer screening. Cancer Biomark. 2025 Jan; 42(1):18758592241313323.
Score: 0.938
-
Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer. Cancer. 2017 Dec 15; 123(24):4886-4894.
Score: 0.557
-
Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. Cancer. 2015 Oct 01; 121(19):3455-64.
Score: 0.477
-
Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial. Oral Oncol. 2021 09; 120:105397.
Score: 0.181
-
Prognostic implications of human papillomavirus status and p16 expression in laryngeal squamous cell carcinoma. Head Neck. 2019 12; 41(12):4151-4163.
Score: 0.160
-
The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncol. 2018 07; 82:91-99.
Score: 0.146
-
Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior. Oral Oncol. 2015 Sep; 51(9):832-8.
Score: 0.119
-
HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Clin Cancer Res. 2015 Jun 15; 21(12):2861-9.
Score: 0.119
-
HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status. Oral Oncol. 2015 Jul; 51(7):662-7.
Score: 0.118
-
Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Cancer Res. 2010 Sep 15; 70(18):7199-208.
Score: 0.085
-
p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis. 2008 Apr; 29(4):875-9.
Score: 0.072
-
Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck. 2008 Jan; 30(1):75-84.
Score: 0.071
-
Joint effect of human papillomavirus exposure, smoking and alcohol on risk of oral squamous cell carcinoma. BMC Cancer. 2023 May 19; 23(1):457.
Score: 0.052
-
Detection accuracy of the Cobas HPV assay for high-risk HPV in head and neck FNA biopsy specimens. Cancer Cytopathol. 2022 07; 130(7):523-530.
Score: 0.047
-
Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis. Cancer. 2021 03 15; 127(6):850-864.
Score: 0.044
-
A TGF-?1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer. Int J Cancer. 2018 09 15; 143(6):1327-1334.
Score: 0.036
-
Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma. Cancer Res. 2013 Oct 01; 73(19):5996-6003.
Score: 0.026
-
Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res. 2010 Mar 01; 16(5):1416-22.
Score: 0.021